Esther Ong

586 total citations
10 papers, 436 citations indexed

About

Esther Ong is a scholar working on Molecular Biology, Infectious Diseases and Microbiology. According to data from OpenAlex, Esther Ong has authored 10 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Microbiology. Recurrent topics in Esther Ong's work include Biochemical and Structural Characterization (3 papers), Cancer-related gene regulation (2 papers) and Antimicrobial Peptides and Activities (2 papers). Esther Ong is often cited by papers focused on Biochemical and Structural Characterization (3 papers), Cancer-related gene regulation (2 papers) and Antimicrobial Peptides and Activities (2 papers). Esther Ong collaborates with scholars based in Singapore, New Zealand and United States. Esther Ong's co-authors include Jeffrey Hill, Kanda Sangthongpitag, Vishal Pendharkar, Vithya Manoharan, Isaac Virshup, Babita Madan, Enrico Petretto, Thomas H. Keller, David M. Virshup and A. Matter and has published in prestigious journals such as Oncogene, BMC Genomics and Bioorganic & Medicinal Chemistry.

In The Last Decade

Esther Ong

10 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esther Ong Singapore	7	285	122	40	39	37	10	436
Jia Gu China	12	184 0.6×	116 1.0×	36 0.9×	45 1.2×	5 0.1×	33	428
Matthew Martin United States	13	343 1.2×	90 0.7×	28 0.7×	19 0.5×	11 0.3×	30	497
Kazuto Nishio Japan	12	228 0.8×	157 1.3×	67 1.7×	36 0.9×	21 0.6×	25	435
Daniel E. Juri United States	11	323 1.1×	111 0.9×	50 1.3×	14 0.4×	45 1.2×	15	552
Wafaa M. Rashed Egypt	9	140 0.5×	62 0.5×	25 0.6×	24 0.6×	11 0.3×	23	400
Carlos Saus Spain	10	150 0.5×	71 0.6×	36 0.9×	29 0.7×	14 0.4×	16	306
Telmo Catarino Portugal	9	231 0.8×	59 0.5×	23 0.6×	53 1.4×	40 1.1×	11	390
Alessandro Barbarulo United Kingdom	12	224 0.8×	158 1.3×	23 0.6×	40 1.0×	13 0.4×	15	459
Hikaru Izawa Japan	10	251 0.9×	126 1.0×	42 1.1×	45 1.2×	9 0.2×	27	421

Countries citing papers authored by Esther Ong

Since Specialization

Citations

This map shows the geographic impact of Esther Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Ong more than expected).

Fields of papers citing papers by Esther Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Ong. The network helps show where Esther Ong may publish in the future.

Co-authorship network of co-authors of Esther Ong

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Ong. A scholar is included among the top collaborators of Esther Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Ong. Esther Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ong, Esther, et al.. (2022). Deep learning for de-convolution of Smad2 versus Smad3 binding sites. BMC Genomics. 23(S1). 525–525. 4 indexed citations

Ng, Fui Mee, et al.. (2021). Designing a leucine‐rich antibacterial nonapeptide with potent activity against mupirocin‐resistant MRSA via a structure–activity relationship study. Chemical Biology & Drug Design. 97(6). 1185–1193. 1 indexed citations

Ng, Fui Mee, et al.. (2017). Screening for a Potent Antibacterial Peptide to Treat Mupirocin-Resistant MRSA Skin Infections. International Journal of Peptide Research and Therapeutics. 23(4). 481–491. 2 indexed citations

Madan, Babita, Nathan Harmston, Soo Yei Ho, et al.. (2015). Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene. 35(17). 2197–2207. 271 indexed citations

Lee, David, et al.. (2015). An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA). Antibiotics. 4(4). 424–434. 13 indexed citations

Xu, Jin, Esther Ong, Jeffrey Hill, Anqi Chen, & Christina L. L. Chai. (2014). Design, synthesis and biological evaluation of FLT3 covalent inhibitors with a resorcylic acid core. Bioorganic & Medicinal Chemistry. 22(23). 6625–6637. 16 indexed citations

Tam, Eric K. W., Tuan Minh Nguyen, Puay Leng Lee, et al.. (2014). 3‐Deazaneplanocin A and Neplanocin A Analogues and Their Effects on Apoptotic Cell Death. ChemMedChem. 10(1). 173–182. 22 indexed citations

Zhang, Wei, Suat Peng Neo, Jayantha Gunaratne, et al.. (2014). Feedback regulation on PTEN/AKT pathway by the ER stress kinase PERK mediated by interaction with the Vault complex. Cellular Signalling. 27(3). 436–442. 31 indexed citations

Xu, Jin, Anqi Chen, Joma Joy, et al.. (2013). Rational Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by Tuning the Reactivity of an Enamide Michael Acceptor. ChemMedChem. 8(9). 1483–1494. 27 indexed citations

10.

Morton, Randall P., et al.. (2009). Elective gastrostomy, nutritional status and quality of life in advanced head and neck cancer patients receiving chemoradiotherapy. ANZ Journal of Surgery. 79(10). 713–718. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact